Literature DB >> 25386491

Application of bethesda system for cervical cytology in unhealthy cervix.

Indu Verma1, Veena Jain2, Tejinder Kaur3.   

Abstract

INTRODUCTION: Women presenting with unhealthy cervix needs to be evaluated with Papanicolaou (Pap) smear for epithelial abnormalities. AIM: To detect epithelial cell abnormalities in unhealthy cervix using the 2001Bethesda system of reporting for cervical cytology and to confirm histopathologicaly the findings of Pap smear.
MATERIALS AND METHODS: In this study, 125 women with clinical diagnosis of unhealthy cervix underwent conventional cytology. Cervical biopsies were taken from abnormal areas seen on colposcopy and sent for histopathology.
RESULTS: Out of 125 Pap smears, 122 were satisfactory for evaluation (19 normal, 86 negative for intraepithelial lesion or malignancy and 17 with epithelial cell abnormality) and 3 were unsatisfactory (one hemorrhagic and two severe inflammation). Out of 17 (13.60%) cases with epithelial cell abnormality, ASC-US was seen in 6 (4.80%), LSIL in 7 (5.60%), HSIL in 1 (0.80%), squamous cell carcinoma in 1 (0.80%), AGC endocervical in 1 (0.80%) and adenocarcinoma in 1 (0.80%) patients. Cervical biopsy was taken in 67 women. Diagnostic accuracy of Pap smear for preinvasive and invasive disease was 81.15% with overall sensitivity and specificity 78.57% and 88.67% respectively and predictive value of 64.71%.
CONCLUSION: Women with clinical diagnosis of unhealthy cervix should be evaluated by cytology to detect any premalignant or malignant lesions. The Bethesda system for cervical cytology reporting should be used universally as it will give a standardized interpretation.

Entities:  

Keywords:  Bethesda system; Papanicolaou (Pap) Smear; Unhealthy cervix

Year:  2014        PMID: 25386491      PMCID: PMC4225943          DOI: 10.7860/JCDR/2014/9620.4893

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  8 in total

1.  Pattern of cervical smear abnormalities using the revised Bethesda system in a tertiary care hospital in Western Saudi Arabia.

Authors:  Fadwa J Altaf; Shagufta T Mufti
Journal:  Saudi Med J       Date:  2012-06       Impact factor: 1.484

2.  The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop.

Authors: 
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

3.  Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop.

Authors:  R J Kurman; D E Henson; A L Herbst; K L Noller; M H Schiffman
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

4.  Evaluation of cytology in unhealthy cervix.

Authors:  S Das; G Mishra; S Panda
Journal:  J Indian Med Assoc       Date:  1984-05

Review 5.  The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Authors:  Diane Solomon; Diane Davey; Robert Kurman; Ann Moriarty; Dennis O'Connor; Marianne Prey; Stephen Raab; Mark Sherman; David Wilbur; Thomas Wright; Nancy Young
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

6.  Accuracy of conventional cytology: results from a multicentre screening study in India.

Authors:  R Sankaranarayanan; S Thara; A Sharma; C Roy; S Shastri; C Mahé; R Muwonge; B Fontanière
Journal:  J Med Screen       Date:  2004       Impact factor: 2.136

7.  Clinicopathological importance of Papanicolaou smears for the diagnosis of premalignant and malignant lesions of the cervix.

Authors:  Mulazim Hussain Bukhari; Kanwal Saba; Samina Qamar; Muhammad Muddasar Majeed; Shahida Niazi; Samina Naeem
Journal:  J Cytol       Date:  2012-01       Impact factor: 1.000

8.  Detection of abnormal cervical cytology in Papanicolaou smears.

Authors:  Manjit Singh Bal; Rishu Goyal; Anil Kumar Suri; Manjit Kaur Mohi
Journal:  J Cytol       Date:  2012-01       Impact factor: 1.000

  8 in total
  6 in total

1.  Increased methylation of human papillomavirus type 16 DNA is associated with the severity of cervical lesions in infected females from northeast China.

Authors:  Wei Wang; Zhengrong Sun; Jianhua Liu; Guili Wang; Zhitao Lu; Weiqiang Zhou; Te Qi; Qiang Ruan
Journal:  Oncol Lett       Date:  2017-03-24       Impact factor: 2.967

2.  HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More.

Authors:  Lihua Chen; Binhua Dong; Hangjing Gao; Huifeng Xue; Diling Pan; Pengming Sun
Journal:  J Inflamm Res       Date:  2020-10-29

3.  HR-HPV viral load quality detection provide more accurate prediction for residual lesions after treatment: a prospective cohort study in patients with high-grade squamous lesions or worse.

Authors:  Lihua Chen; Binhua Dong; Qiaoyu Zhang; Xiaodan Mao; Wenyu Lin; Guanyu Ruan; Yafang Kang; Pengming Sun
Journal:  Med Oncol       Date:  2020-03-30       Impact factor: 3.064

4.  Human Papillomavirus Genotyping among Different Cervical Smears in Duhok/Iraq.

Authors:  Intisar Salim Pity; Hanaa Mohammed Abdo; Amer Abdalla Goreal
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

5.  Comparison of Diagnostic Methods in Detection of Squamous Cell Abnormalities in Iranian Women with Abnormal Pap's Smear Test and Associated Demographic and Issues.

Authors:  Fatemeh Samiee Rad; Mahdi Ghaebi; Simin Zarabadipour; Arezoo Bajelan; Fatemeh Pashazade; Mehri Kalhor; Amane Barikani
Journal:  Iran J Pathol       Date:  2020-02-19

6.  Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China.

Authors:  Qiaoyu Zhang; Binhua Dong; Lihua Chen; Tingting Lin; Yao Tong; Wenyu Lin; Haifeng Lin; Yuqin Gao; Fen Lin; Pengming Sun
Journal:  Cancer Manag Res       Date:  2020-04-01       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.